electroCore, Inc. (ECOR) Fair Value 2026

ECOR · Electromedical & Electrotherapeutic Apparatus ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

6.2 /10

32 fundamental signals · 10 models active

Value Trap Risk

SAFE (24/100)

Quick Summary — As of 2026-07-15, electroCore, Inc. (ECOR) trades at $6.03, approximately 142% above CirclFi’s Bayesian DCF fair value of $2.49. QOC: 6.2/10. Value Trap Risk: 24/100 (SAFE). 10/13 models active.

Key Facts

Ticker
ECOR
Price
$6.03
Quality Score
6.2/10
Value Trap Risk
24/100
Models Active
10/13
Last Updated
Strength: Earnings Power Value suggests +38.9% upside with 21% confidence
Risk: Majority of models suggest overvaluation

Is electroCore, Inc. (ECOR) Undervalued or Overvalued in 2026?

According to CirclFi’s 10-model valuation engine, electroCore, Inc. (ECOR) appears overvalued as of : the median of 10 independent fair value estimates is $5.23, 13.3% below the current price of $6.03. Estimates range from $1.16 to $8.50. ECOR scores 6.2/10 on fundamental quality and 24/100 on value-trap risk.

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy electroCore, Inc. Stock in 2026? →

Valuation Matrix

10 Intrinsic Value Models vs. Current Price ($6.03)

Core Models (Unlocked)
Model Fair Value Upside
Bayesian DCF
Low Conviction
 $2.49 -58.6%
Earnings Power Value
Medium Conviction
 $8.37 +38.9%
CUCE Ensemble
Low Conviction
 $4.63 -23.3%
First Chicago
Low Conviction
 $5.98 -0.9%

Unlock the Full Matrix

Access 6 additional models including EROIC Spread, ML-RIV, and more.

$1.30 / day

Billed monthly ($39/mo) or annually ($299/yr)

Unlock All 10 Models →

Cancel anytime · No contracts · Instant access

What Is electroCore, Inc. (ECOR) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, electroCore, Inc.'s intrinsic value is estimated at a composite $5.06, showing conflicting signals at the current price of $6.03. While the average implied return is -16.1%, model disagreement is elevated with a gap of +121.6% between the most bullish and bearish estimates. The most optimistic model, PWERM, places fair value at $8.50 (+40.9%), while ML-RIV — the most conservative — estimates $1.16 (-80.7%). This +121.6% gap reflects genuine analytical uncertainty about electroCore, Inc.'s intrinsic worth.

What Do the Models Say About ECOR?

10 of 13 models are currently active for ECOR. Of these, 3 models suggest upside while 7 models suggest overvaluation. The Bayesian DCF estimates ECOR's intrinsic value at $2.49, implying -58.6% downside from the current price. See which stocks rank higher →

How Does ECOR Rank in Electromedical & Electrotherapeutic Apparatus?

Among 25 Electromedical & Electrotherapeutic Apparatus stocks, ECOR ranks #15 by Quality of Company score. CirclFi's QOC score of 6.2/10 evaluates 32 fundamental signals. A score of 6.2 indicates above-average quality.

electroCore, Inc. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.

Is ECOR a Value Trap?

CirclFi's Value Trap algorithm assigns ECOR a score of 24/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

10 of 13 models are active for electroCore, Inc.. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Quality of Company (QOC) framework, which evaluates 32 signals including margin stability, revenue growth trajectory, leverage, and free cash flow generation, electroCore, Inc. is rated at 6.2/10. This solid-tier score maintains reasonable quality metrics with some areas for improvement.

The gap between the most bullish and bearish model spans +121.6% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every ECOR valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across ECOR's 10 active models, average confidence is 26%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy electroCore, Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Electromedical & Electrotherapeutic Apparatus Stocks Should You Also Analyze?

8 related Electromedical & Electrotherapeutic Apparatus stocks with 13-model coverage

INMDInMode Ltd.QOC 9.9ELMDElectromed, Inc.QOC 9.4LIVNLivaNova PLCQOC 9.1CNMDCONMED CorporationQOC 8.9ITGRInteger Holdings CorporationQOC 8.3MDTMedtronic plc.QOC 8.1TMDXTransMedics Group, Inc.QOC 8.0AXGNAxoGen, Inc.QOC 7.9

Read investment analysis: INMD · ELMD · LIVN · CNMD · ITGR

Frequently Asked Questions About electroCore, Inc.

What is electroCore, Inc.'s intrinsic value in 2026?

Based on CirclFi's 13-model analysis, electroCore, Inc. (ECOR) has multiple fair value estimates. The Bayesian DCF model runs 10,000 Monte Carlo simulations with jump-diffusion to estimate intrinsic value at $2.49. The Quality of Company score is 6.2/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is ECOR overvalued or undervalued right now?

At $6.03, 3 of 10 active models suggest ECOR may be undervalued, while 7 indicate potential overvaluation. The median of all 10 fair value estimates is $5.23, 13.3% below the current price of $6.03 — a consensus view that ECOR is overvalued. The assessment depends on which methodology best fits electroCore, Inc.'s business model in Electromedical & Electrotherapeutic Apparatus.

What does a Quality of Company score of 6.2 mean for ECOR?

electroCore, Inc.'s QOC of 6.2/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores between 5-7 reflect moderate fundamentals with areas for improvement.

How many valuation models does CirclFi run on ECOR?

CirclFi analyzes ECOR with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 10 of 13 are active for this stock. Read the full methodology →

Is ECOR a value trap in 2026?

electroCore, Inc.'s Value Trap score is 24/100 (SAFE). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap. Browse stocks by value-trap risk →

Cite this analysis — “According to CirclFi’s 10-model valuation engine, electroCore, Inc. (ECOR) has a median fair value of $5.23 — 13.3% below the current price of $6.03 — as of 2026-07-15.” Source: circlfi.com/stock/ECOR/ · Methodology

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 10 mathematical frameworks give you clarity on ECOR.

Unlock All 10 Fair Values — $39/mo

Cancel anytime · Less than a cup of coffee · Instant access